Globally respected NGO leader joins Orbis to meet the growing global need for eye care
NEW YORK, Jan. 12, 2026 /PRNewswire/ — Global eye care NGO Orbis International is pleased to welcome Kathleen Sherwin as President &…
Not all urban renewal projects need to start with a declaration for an entire neighborhood or massive complexes of thousands of apartments. On the ground, more and more projects are advancing precisely on a small and focused scale – targeting a…
Our portfolio companies are building technology that rearchitects how we build, work, and thrive together. But transformative technology…
AbbVie and RemeGen Announce Exclusive Licensing Agreement to Develop A Novel Bispecific Antibody for Advanced Solid Tumors
– RC148 is a novel PD-1/VEGF bispecific antibody being evaluated in multiple advanced solid tumors including…
Behind the promise of renewal lies a less discussed side – the complex reality of the veteran residents, those who have lived for years in old buildings and are now required to exchange their familiar home for a new dream, which does not always…
The Company finishes 2025 with strong Q4 performance, expects 20-22% revenue growth in 2026, and promotes Ross Muken to CEO
BOSTON and ROLLE, Switzerland, Jan. 12, 2026…
Ramp up of Phase 1 concentrator advancing to plan; first sale of concentrate completed
Shaft #3 on track for April 2026; five-fold increase in hoisting capacity to 5 million tonnes per annum supporting Phase 1 and Phase 2 expansion
Phase 2 on track,…
NIS 1.3 billion was transferred to the fund in 2025, up from NIS 1 billion in 2024.
Join us on 5 and 6 February for the Innovative Neuromorphic Vision Sensors (INVISIONS) workshop organised by the JRC. The event will be in hybrid format, both in person and online. Registrations are open until 28 January 2026.
The workshop aims…